Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
02/04/1998 | EP0821956A1 Method for treating disruptive behavior disorders |
02/04/1998 | EP0821955A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating bipolar disorder |
02/04/1998 | EP0821954A1 Method for treating mental retardation |
02/04/1998 | EP0821684A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
02/04/1998 | EP0821683A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
02/04/1998 | EP0821682A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex |
02/04/1998 | EP0821681A1 Naphthalene derivatives, method of preparation and use |
02/04/1998 | EP0821676A1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
02/04/1998 | EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
02/04/1998 | EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE |
02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
02/04/1998 | CN1172482A Antipsychotic 4 (1 H -indolyl -1 -YL) -1 -substituted piperidine derivatives |
02/04/1998 | CN1172469A 2 -aminoindans as selective dopamine D3 ligands |
02/04/1998 | CN1172431A Use of melatonin for treating patients suffering from drug addiction |
02/04/1998 | CN1172104A Substituted lndanylidineacetylguanidines, process for their preparation, their use as medicaments of diagnostic and medicaments containing them |
02/04/1998 | CN1037269C Method for preparing 3 -quinuclidinyl ester |
02/03/1998 | US5714607 Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
02/03/1998 | US5714502 Atypical neuraleptics having no cataleptic side effects; schizophrenia, antidepressants; analgesics; hypotensive agents; extrapyramidal disorders |
02/03/1998 | US5714500 2-phenyl- and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
02/03/1998 | US5714498 Benzimidazole derivatives |
02/03/1998 | US5714495 Anxiolytic agents, melatonin receptors for treating psychological disorders and analgesics, sleep disorders |
02/03/1998 | US5714489 2,3(1H,4H)quinoxalinedione |
02/03/1998 | US5714487 2,7-substituted octahydro-pyrrolo 1,2-a!pyrazine derivatives |
02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
02/03/1998 | US5714471 Useful in indicating neurodegenerative disorders characterized by deposition of cerebral amyloid |
02/03/1998 | US5714468 Injecting neurotoxins into localized pain sites |
02/03/1998 | CA2098989C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
02/03/1998 | CA1339660C Derivatives of cyclohexane |
01/29/1998 | WO1998003670A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
01/29/1998 | WO1998003541A1 Conantokins |
01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |
01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
01/29/1998 | WO1998003503A1 N-benzenesulphonyl-l-proline derivatives as bradykinin b2 agonists |
01/29/1998 | WO1998003496A1 Furan nitrone compounds |
01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
01/29/1998 | WO1998003472A1 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof |
01/29/1998 | WO1998003469A1 Benzoylpropionic acid ester derivatives |
01/29/1998 | WO1998003197A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
01/29/1998 | WO1998003189A1 Use of conantokins |
01/29/1998 | WO1998003173A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
01/29/1998 | WO1998003167A1 Isobutylgaba and its derivatives for the treatment of pain |
01/29/1998 | WO1998003059A1 Galanin |
01/29/1998 | WO1997037630A3 Spiro(2h-1-benzopyran-2,4'-piperidine)-4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them |
01/29/1998 | DE19630035A1 Tramadol Multiple Unit Formulierungen Tramadol multiple unit formulations |
01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
01/29/1998 | CA2262007A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
01/29/1998 | CA2261743A1 N-benzenesulphonyl-l-proline derivatives as bradykinin b2 antagonists |
01/29/1998 | CA2261570A1 Use of conantokins |
01/29/1998 | CA2261568A1 Conantokins |
01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
01/29/1998 | CA2260825A1 Furan nitrone compounds |
01/29/1998 | CA2260752A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
01/29/1998 | CA2258074A1 Benzoylpropionic acid ester derivatives |
01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
01/28/1998 | EP0820507A1 Ndf peptides |
01/28/1998 | EP0820457A1 Benzimidazole derivatives |
01/28/1998 | EP0820456A1 1,2,4-triazolo 4,3-b]pyridazine derivatives and their use |
01/28/1998 | EP0820455A1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
01/28/1998 | EP0820454A1 Anellated beta-carbolines |
01/28/1998 | EP0820451A1 Novel heterocyclic compounds |
01/28/1998 | EP0820450A1 Novel heterocyclic compounds |
01/28/1998 | EP0820444A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
01/28/1998 | EP0820443A1 Novel heterocyclic compounds |
01/28/1998 | EP0820442A1 Novel heterocyclic compounds |
01/28/1998 | EP0820438A1 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same |
01/28/1998 | EP0820434A1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
01/28/1998 | EP0820284A1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
01/28/1998 | EP0820283A1 Lactacystin analogs |
01/28/1998 | CN1171787A Pyridazinoquinoline compounds |
01/28/1998 | CN1171786A Hydrate for medicinal use |
01/28/1998 | CN1171743A Novel tumor suppressor gene HIC-1 |
01/28/1998 | CN1171401A New 3-(piperid-4-yl)-1, 2 -benzisoxazole and 3-(piperazin-4-yl) -1, 2-benzisoxazole compounds, processes for their preparation and pharmaceutical compositions containing them |
01/28/1998 | CN1171396A 4-hydroxy-piperdine derivatives |
01/28/1998 | CN1171264A Calming and desadening pill preparing process thereof |
01/28/1998 | CN1171253A Isatis root preparation and compounding process and use thereof |
01/28/1998 | CN1037201C 多元溶剂清洗系统 Multiple solvent cleaning system |
01/27/1998 | US5712312 Melatoninergic receptor ligands, treatment of sleep disorders |
01/27/1998 | US5712303 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity |
01/27/1998 | US5712301 Use of dexmedetomidine for treating ethanol-induced neurodegeneration |
01/27/1998 | US5712299 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives |
01/27/1998 | US5712297 Piperdine compounds and their preparation and use |
01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
01/27/1998 | US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof |
01/27/1998 | US5712287 Method of treating urinary bladder dysfunctions |
01/27/1998 | US5712277 Use of 3,5-diamino-6-(2,3-dichlororophenyl) -1,2,4-triazine for the treatment of pain and oedema |
01/27/1998 | US5712276 Treating nervous system disorders |
01/27/1998 | US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
01/27/1998 | US5712272 Treatment of neurological disorders with benz(b)azepine compounds |
01/27/1998 | US5712271 Method of treating urinary bladder dysfunctions |
01/27/1998 | US5712269 M2 receptor ligand for the treatment of neurological disorders |
01/27/1998 | US5712111 DNA encoding bradykinin B1 receptor |
01/27/1998 | CA2194564C Aqueous risperidone formulations |
01/27/1998 | CA2138018C Process and intermediates for bis-aza-bicyclic anxiolytic agents |
01/27/1998 | CA2024162C Benzazabicyclo carbamates as novel cholinesterase inhibitors |